M. Hultén

Infrequent methylation of CDKN 2 A ( MTS 1 p 16 ) and rare mutation of both CDKN 2 A and CDKN 2 B ( MTS 2 Ip 15 ) in primary astrocytic tumours

T. Sorahan, R. Lancashire, M. Hultén, 2007 .

The influence of various chemicals on the surface structure and the antigenicity of syngeneic glioma cells.

K. Zänker, D. Stavrou, T. Bilzer, 1981, Anticancer research.

The humoral antibody response of rats immunized with chemically modified syngeneic brain cells and glioma cells

D. Stavrou, T. Bilzer, M. Hultén, 1980, International journal of cancer.

Immunological aspects of experimental brain tumors (review).

K. Haglid, K. Zänker, D. Stavrou, 1982, Anticancer research.

Chemical modification and antigenicity of glioma cells.

D. Stavrou, T. Bilzer, M. Hultén, 1981, Acta neuropathologica. Supplementum.

What is to be done with the XYY fetus?

M. Hultén, W. Farrant, 1979, British medical journal.

Reactivity of tumor-infiltrating, blood, spleen and lymph node lymphocytes against syngeneic glioma target cells.

D. Stavrou, T. Bilzer, E. Kaldrymidou, 1981, Anticancer research.